Titan Pharmaceuticals Reports Second Quarter 2017 Financial Results


SOUTH SAN FRANCISCO, Calif., Aug. 9, 2017 /PRNewswire/  Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery technology, today reported financial results for the second quarter 2017, and provided an update on its business. Business highlights include: Financing On July 27, Titan entered [ ] The post Titan Pharmaceuticals Reports Second Quarter 2017 Financial Results appeared first on STL News.
http://bit.ly/2uoT4V4

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s